The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy.
Saved in:
| Title: | The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy. |
|---|---|
| Authors: | Murray, Nigel P.1,2 nigelpetermurray@gmail.com, Aedo, Socrates2, Fuentealba, Cynthia1, Reyes, Eduardo3,4, Minzer, Simone1, Salazar, Aníbal1 |
| Source: | Ecancermedicalscience. 2018, Vol. 12 Issue 844-874, p1-11. 11p. |
| Database: | Academic Search Ultimate |
| ISSN: | 17546605 |
|---|---|
| DOI: | 10.3332/ecancer.2018.844 |
